Linking the p53 tumour suppressor pathway to somatic cell reprogramming
Salk Institute for Biological Studies · Astellas Pharma (Japan) · +3 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,116
total citations
- FWCI
- 58.46
- Percentile
- 100%
- References
- 41
Citations per year
Authors
8- TKTeruhisa KawamuraCorresponding
Salk Institute for Biological Studies
- JSJotaro Suzuki
Astellas Pharma (Japan), Salk Institute for Biological Studies
- YVYunyuan V. Wang
Salk Institute for Biological Studies
- SMSergio Ménendez
Center of Regenerative Medicine in Barcelona
- LBLaura Batlle‐Morera
Center of Regenerative Medicine in Barcelona
Topics & keywords
Topics
Keywords
- Reprogramming
- Somatic cell
- Induced pluripotent stem cell
- Biology
- SOX2
- Cell biology
- KLF4
- Gene silencing
No related works found for this paper.